pillbase.ru

Isturisa

Active substance: osilodrostat

TABLET, COATED · OSILODROSTAT PHOSPHATE 5 mg/1

United StatesActive

Marketing holder: Recordati Rare Diseases, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Isturisa
    osilodrostat phosphate
    EMEA/H/C/004821
    Recordati Rare Diseases
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-77c3-7718-ada5-0cab6dc73e96,01a1208d-4380-7ccd-b0e1-08f30629f79a,01a1208e-78fe-7199-9e92-aff2d5ebffb5,01a12093-c0d4-77dd-a593-f4154193a278;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
55292-321
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 55292-321 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 55292-321 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 55292-321 · Verified 2026-10-09 · open in source